Published in BMJ on August 17, 1996
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet (2005) 3.97
No escape: HIV transmission in jail. BMJ (1993) 3.91
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Revised guidelines for HIV infected health care workers. BMJ (1993) 3.16
Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen. Proc Natl Acad Sci U S A (1986) 2.76
Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ (1995) 2.66
Inside methodology: HIV surveillance in prisons. AIDS (1994) 2.39
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature (1981) 2.10
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Uptake of confidential, named HIV testing in Scottish prisons. Lancet (1992) 2.01
The structure of the human CD2 gene and its expression in transgenic mice. EMBO J (1988) 2.00
Prisoners' uptake of confidential, named HIV testing. Lancet (1992) 1.99
A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev (1979) 1.91
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) (2001) 1.82
Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev (1996) 1.77
Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis. Lancet (1987) 1.61
Adverse effects of intravenous immunoglobulin. Drug Saf (1993) 1.61
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
Secretion of electrolytes by the pancreas of the anaestetized rat. J Physiol (1975) 1.60
Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol (1983) 1.54
Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood (1993) 1.54
A live human B-cell activator operating in isolation of other cellular influences. Scand J Immunol (1979) 1.54
No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49
Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland. Int J STD AIDS (1997) 1.48
Primary antibody deficiency in adults. Lancet (1991) 1.47
Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM (1999) 1.47
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol (1997) 1.42
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut (2003) 1.42
Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis (1991) 1.40
Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom. Arch Dis Child (2005) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Recent non-sterile inoculation injuries to dental professionals in the Lothian region of Scotland. Br Dent J (1994) 1.39
Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay. Immunology (1979) 1.39
The effects of papain, trypsin and phospholipase A on rosette formation. Transplantation (1973) 1.39
Increased expression of the CD45RO (memory) antigen on T cells in HIV-infected children. AIDS (1991) 1.37
A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res (2000) 1.37
Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol (1990) 1.26
Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol (1992) 1.26
Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol (2003) 1.23
The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods (1984) 1.21
Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol (2000) 1.21
Diphtheria, pertussis, and tetanus vaccination. Lancet (1992) 1.21
The murine homologue of the T lymphocyte CD2 antigen: molecular cloning, chromosome assignment and cell surface expression. Eur J Immunol (1987) 1.18
Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J Exp Med (1983) 1.18
Rosette inhibition test in severely burned patients. Br Med J (1973) 1.17
Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics (2000) 1.16
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine. Pediatr Infect Dis J (1993) 1.15
Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect Immun (1999) 1.15
The multiple complexes formed by the interaction of platelet factor 4 with heparin. Biochem J (1980) 1.13
Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS (1996) 1.11
Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases. Qual Health Care (1995) 1.11
Second anonymous HIV surveillance in Saughton Prison, Edinburgh: prisoners give a lead to other heterosexuals on being HIV tested. AIDS (1993) 1.10
The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol (2014) 1.08
Donor-specific bone marrow and long-term survival of allogeneic arm transplant. Lancet (1999) 1.08
Role of Ca2+ ions in the regulation of intramitochondrial metabolism in rat epididymal adipose tissue. Evidence against a role for Ca2+ in the activation of pyruvate dehydrogenase by insulin. Biochem J (1984) 1.06
Bile mediates intestinal pathology in endotoxemia in rats. Infect Immun (2000) 1.06
Murine CD2 gene expression during fetal thymus ontogeny. Eur J Immunol (1988) 1.06
Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev (1981) 1.05
The Rosette inhibition test in skin-grafted patients. Br Med J (1974) 1.05
Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol (1995) 1.05
Drugs in British prisons. Policies need outside scrutiny if they are to do more good than harm. BMJ (1998) 1.05
Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med (1990) 1.04
Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood (1991) 1.04
Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors. Clin Exp Immunol (2004) 1.04
Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest (1987) 1.03
Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J (1992) 1.02
ELISA determination of IgG antibodies to pneumococcal capsular polysaccharides in a group of children. J Immunol Methods (1987) 1.01
Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am J Trop Med Hyg (1986) 1.01
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology (1996) 1.01
Persistence of the effect of insulin on pyruvate dehydrogenase activity in rat white and brown adipose tissue during the preparation and subsequent incubation of mitochondria. Biochem J (1984) 1.01
Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method. Clin Exp Immunol (2005) 1.00
Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol (2000) 1.00
Mannose binding lectin polymorphisms are associated with early age of disease onset and autoimmunity in common variable immunodeficiency. Scand J Immunol (2000) 0.99
Species conservation of the T cell lymphocyte CD2 cell surface antigen. Eur J Immunol (1988) 0.99
High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens (2002) 0.99
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. Int J STD AIDS (1994) 0.99
The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant (1993) 0.98
Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood (1980) 0.97
Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol (1986) 0.96
Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients. Clin Exp Immunol (1993) 0.96
Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells. Cell Immunol (1986) 0.96
Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol (2008) 0.96
Method used to identify previously undiagnosed infections in the HIV outbreak at Glenochil prison. Epidemiol Infect (1999) 0.96
Enhancement of interleukin-4 production by pertussis toxin. Infect Immun (1993) 0.96
Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease. Lancet (1987) 0.96
Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol (1994) 0.95
Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med (1993) 0.94
IgE sequences in individuals living in an area of endemic parasitism show little mutational evidence of antigen selection. Scand J Immunol (2011) 0.94
Transmission of HIV in prison. BMJ (1993) 0.93
Antipolysaccharide antibodies in 450 children with otitis media. Clin Exp Immunol (1997) 0.93
Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens (2007) 0.93
Glucose-6-phosphate isomerase. Philos Trans R Soc Lond B Biol Sci (1981) 0.93
Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax (2000) 0.93
T cell regulation in adult transplantation tolerance. J Immunol (1996) 0.93
Human cytomegalovirus infection is not increased in common variable immunodeficiency. J Clin Immunol (1996) 0.92
Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin. Immunology (1994) 0.92